Chlorpromazine Hydrochloride Injection
FDA Label NDC 70771-1779

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Chlorpromazine Hydrochloride (NDC 70771-1779). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1778-1

chlorproMAZINE Hydrochloride Injection, USP

25 mg/mL

For Deep Intramuscular Use

Discard unused portion

1 mL Single-Dose Vial

Rx only

25 mg/ml (Bcbd52b5 2981 407b B260 0568efab3890 01)

25 mg/ml (Bcbd52b5 2981 407b B260 0568efab3890 01)

NDC 70771-1778-7

chlorproMAZINE Hydrochloride Injection, USP

25 mg/mL

For Deep Intramuscular Use

Discard unused portion

25 x 1 mL Single-Dose Vial

Rx only

25mg/ml (Bcbd52b5 2981 407b B260 0568efab3890 02)

25mg/ml (Bcbd52b5 2981 407b B260 0568efab3890 02)

* Please review the disclaimer below.